Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shohei Hashiguchi is active.

Publication


Featured researches published by Shohei Hashiguchi.


Journal of The Chemical Society-perkin Transactions 1 | 1988

Synthesis of γ-lactam analogues of carbapenems with substituted-thio groups at the C-3 position

Shohei Hashiguchi; Hideaki Natsugari; Michihiko Ochiai

γ-Lactamanalogues of carbapenems{(7S)-7-acylamino-2-carboxy-3-(substituted-thio)-1-azabicyclo[3.3.0]oct-2-en-8-ones}(2) were synthesized starting from L-aspartic acid. Condensation of the oxo ester (4) with 2, 4-dimethoxybenzylamine followed by cyclization gave preferentially the E-γ-lactam (6), which was transformed into the 3, 5-cis-5-carboxymethyl-γ-lactam cis-(9)via stereoselective catalytic reduction. The major product cis-(9) and its trans-isomer were converted into compound (2)via a carbene insertion reaction. The antibacterial activity of the trans-acetamidoethylthio derivative (23) slightly exceeded that of the corresponding cis-derivative (17).


Journal of The Chemical Society-perkin Transactions 1 | 1991

Stereoselective synthesis of sperabillins and related compounds

Shohei Hashiguchi; Akira Kawada; Hideaki Natsugari

Bakers yeast reduction of methyl (4S)-4-(tert-butoxycarbonylamino)-3-oxopentanoate 6 stereoselectively afforded methyl (3R,4S)-erythro-4-Boc-amino-3-hydroxypentanoate 7, which was converted into the erythro keto δ-lactone 3a in three steps. The threo keto δ-lactones 3b–c were diastereoselectively prepared by cyclocondensation of N-Boc D- and L-alaninal 4 with 1 -methoxy-1, 3-bis(trimethylsiloxy)buta-1,3-diene 9 in the presence of a catalytic amount of tin(II) chloride. Recluctive amination of the keto lactones 3 using 5% platinum on carbon as catalyst in an acidic medium stereoselectively afforded the N-protected 3,6-diamino-5-hydroxyheptanoic acid lactones 1 with 3,5-anti stereochemistry. These were transformed into the enantiomerically pure sperabillin 17 and negamycin 20 derivatives in good yields. The configuration of sperabillin B and D was determined to be (3R,5R,6R) by comparison of the synthetic amino lactone 1e with a degradation product of sperabillin B and by the successful transformation of the synthetic amino lactone 1b into sperabillin D.


Journal of the American Chemical Society | 1995

Asymmetric Transfer Hydrogenation of Aromatic Ketones Catalyzed by Chiral Ruthenium(II) Complexes

Shohei Hashiguchi; Akio Fujii; Jun Takehara; Takao Ikariya; Ryoji Noyori


Journal of the American Chemical Society | 1995

Practical Enantioselective Hydrogenation of Aromatic Ketones

Takeshi Ohkuma; Hirohito Ooka; Shohei Hashiguchi; Takao Ikariya; Ryoji Noyori


Bioorganic & Medicinal Chemistry | 2003

TAK-599, a novel N-Phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties

Tomoyasu Ishikawa; Nobuyuki Matsunaga; Hiroyuki Tawada; Noritaka Kuroda; Yutaka Nakayama; Yukio Ishibashi; Mitsumi Tomimoto; Yukihiro Ikeda; Yoshihiko Tagawa; Yuji Iizawa; Kenji Okonogi; Shohei Hashiguchi; Akio Miyake


Journal of Infection and Chemotherapy | 2004

In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599

Yuji Iizawa; Junko Nagai; Tomoyasu Ishikawa; Shohei Hashiguchi; Masafumi Nakao; Akio Miyake; Kenji Okonogi


Archive | 2000

Cyclic amine compounds as ccr5 antagonists

Shinichi Imamura; Shohei Hashiguchi; Taeko Hattori; Osamu Nishimura; Naoyuki Kanzaki; Masanori Baba; Yoshihiro Sugihara


Archive | 1996

Process for preparating optically active compounds

Takao Ikariya; Shohei Hashiguchi; Jun Takehara; Nobuyuki Uematsu; Kazuhiko Matsumura; Ryoji Noyori; Akio Fujii


Bioorganic & Medicinal Chemistry | 2005

CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives

Shinichi Imamura; Youichi Nishikawa; Takashi Ichikawa; Taeko Hattori; Yoshihiro Matsushita; Shohei Hashiguchi; Naoyuki Kanzaki; Yuji Iizawa; Masanori Baba; Yoshihiro Sugihara


Chemical & Pharmaceutical Bulletin | 2004

CCR5 antagonists as anti-HIV-1 agents. 1. Synthesis and biological evaluation of 5-oxopyrrolidine-3-carboxamide derivatives.

Shinichi Imamura; Yuji Ishihara; Taeko Hattori; Osamu Kurasawa; Yoshihiro Matsushita; Yoshihiro Sugihara; Naoyuki Kanzaki; Yuji Iizawa; Masanori Baba; Shohei Hashiguchi

Collaboration


Dive into the Shohei Hashiguchi's collaboration.

Top Co-Authors

Avatar

Yuji Iizawa

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Naoyuki Kanzaki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Shinichi Imamura

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tomoyasu Ishikawa

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yoshihiro Sugihara

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge